Kenji Kosaka

Chugai Pharma (United States) — United States

Medicine · Health Sciences

60h-index25.5kcitations401works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(110), Parkinson's Disease Mechanisms and Treatments(99), Dementia and Cognitive Impairment Research(43), Ginkgo biloba and Cashew Applications(30), Neurological disorders and treatments(27)

Publications401 total

Effects of Transcranial Weak Ultrasonic Stimulation on Parkinson’s Symptoms
Japanese Journal of Complementary and Alternative Medicine·2022Open Access
Development of DLC Film Coating Technology to Achieve both High Performance and High Productivity Utilizing High-Density Plasma
Journal of The Surface Finishing Society of Japan·2022Open Access
Relationship between Thoracic Mobility and Shoulder Joint Function in Patients with Frozen Shoulder
Rigakuryoho Kagaku·2022Open Access
Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled Trial
American Journal of Geriatric Psychiatry·2021· 16 citedOpen Access
When does cerebral β‐amyloid deposition begin in Lewy body dementia?
Neurology and Clinical Neuroscience·2020· 3 cited
Intra-rater and Inter-rater Reliability of a Precordial Flexibility Test
Rigakuryoho Kagaku·2020Open Access
Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: A phase 3 randomized clinical trial
Parkinsonism & Related Disorders·2019· 40 citedOpen Access
Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients with Dementia with Lewy Bodies: A Phase III Trial (P4.1-011)
Neurology·2019· 1 cited
Long-term Efficacy of Zonisamide on Parkinsonism in Dementia with Lewy Bodies: A Post-hoc Analysis of Phase 3 Trial (P4.1-012)
Neurology·2019
<sup>123</sup>I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study
Journal of Neurology Neurosurgery & Psychiatry·2018· 63 cited
Adjunct zonisamide to levodopa for DLB parkinsonism
Neurology·2018· 63 citedOpen Access
Zonisamide improves Parkinsonism in Dementia with Lewy Bodies (DLB): A randomized double-blind placebo-controlled Phase 3 study
Parkinsonism & Related Disorders·2018
Zonisamide improves DLB parkinsonism: A randomized double-blind placebo-controlled phase 3 study
Journal of the Neurological Sciences·2017· 1 cited
Kurauchi, Kazuta (1896–1988)
The Blackwell Encyclopedia of Sociology·2017
Diagnosis and management of dementia with Lewy bodies
Neurology·2017· 4.2k citedOpen Access
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
Newcastle University ePrints (Newcastle Univesity)·2017· 379 citedOpen Access
123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies
Psychiatry Research Neuroimaging·2017· 20 cited
History and Latest Concepts of Lewy Body Disease and Dementia with Lewy Bodies
2016· 1 cited
Dementia with Lewy Bodies
2016· 4 cited
Behavioral and Psychological Symptoms of Dementia
2016· 4 cited
page 1 of 21Next →

Frequent Co-authors

Eizo Iseki(17), Heii Arai(8), Hiroyasu Akatsu(8), Takashi Togo(7), Takayuki Yamamoto(7), Wami Marui(7), Etsuro Mori(6), Ian G. McKeith(5), Dennis W. Dickson(5), Douglas Galasko(5), Masahito Yamada(5), Haruhiko Akiyama(5), Masanori Kato(5), Omi Katsuse(5), Carol F. Lippa(4), Dag Aarsland(4), Clive Ballard(4), Bradley F. Boeve(4), John Q. Trojanowski(4), Hiroshige Fujishiro(4)